GREY:CNTTQ - Post by User
Comment by
bloozguyon Apr 22, 2018 1:32pm
69 Views
Post# 27923452
RE:Apotex article
RE:Apotex articleI wouldn't worry about this article. They are struggling with issues unrelated to cannabis and nothing was in the works that I'm awarevof so there is nothing in jeopardy, in fact the mgmt turnover may be a good segue to re address the partnership opportunity. It's a long term leveragr plan for TRST ...Apotex is a couple billion $ company that treats tens of thousands of epilepsy patients in Canada via their generic drugs which often are in short supply. Sooner or later there will be some convincing trials that will lead to some degree of conversion to a CBD alternative or compliment therapy. I think the passing of the Sherman's put a hold on a lot of things and no doubt TRST is not likely a priority until well after legalization. But it's a great iron in the fire and if the stock continues to drift (which it may) it will just be following the sector which is still under a lot of pressure.
Middleaged wrote:
globe and mail article on apotex. Anyone see the article today. Hopefully this doesn't have a negative impact on Monday's sp.